CELCUITY INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.54 USD | -2.45% |
|
-0.45% | +6.66% |
Chart calendar Celcuity Inc.
ebbec6a50712e03d711c3047.t9DnyKNvZz1hLOM0_D8bYrnWuUqrJ24rgytdu-pvaPs.zaeG_9ZcCAwAS7V5hlhMBd6A7zyGUBp51Uxp09wLB77zpaWAmhdWaS5Z2w~6cce42dbb46251ce56c687e9b68dc44a
Upcoming events on Celcuity Inc.
Past events on Celcuity Inc.
| 15/08/2024 02:00 am | Q2 2024 Earnings Call |
| 15/08/2024 01:31 am | Q2 2024 Earnings Release |
| 06/06/2024 07:30 pm | Jefferies Global Healthcare Conference |
| 16/05/2024 02:00 am | Q1 2024 Earnings Call |
| 16/05/2024 01:31 am | Q1 2024 Earnings Release |
| 09/05/2024 07:30 pm | Annual General Meeting |
| 17/04/2024 07:30 pm | Stifel Virtual Targeted Oncology Days Conference - Fireside Chat |
| 11/04/2024 11:45 pm | Needham Healthcare Conference - Fireside Chat |
| 28/03/2024 02:00 am | Q4 2023 Earnings Call |
| 28/03/2024 01:31 am | Q4 2023 Earnings Release |
| 13/03/2024 06:10 pm | Leerink Partners Global Biopharma Conference |
| 07/03/2024 12:40 am | TD Cowen Health Care Conference - Fireside Chat |
| 06/12/2023 11:30 pm | San Antonio Breast Cancer Symposium - PO1-24-04 |
| 29/11/2023 11:00 pm | Evercore ISI HealthCONx Conference |
| 16/11/2023 02:30 pm | Jefferies London Healthcare Conference |
| 15/11/2023 02:40 am | Stifel Healthcare Conference |
| 13/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 13/11/2023 05:35 pm | Q3 2023 Earnings Release |
| 21/09/2023 07:30 pm | Investor Meeting |
| 11/08/2023 02:00 am | Q2 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 3,86 | 61,7 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -66,1 -66,5 0.62% | -107 | -129 | -149 |
|
EBIT Million USD | Released Forecast Spread | -28,4 -28,0 -1.15% | -39,4 -38,9 -1.34% | -66,2 -65,1 -1.74% | -100 | -140 | -156 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,6 -29,3 -1.09% | -40,4 -40,0 -0.98% | -63,8 -62,8 -1.63% | -98,2 | -126 | -130 |
|
Net income Million USD | Released Forecast Spread | -29,6 -29,1 -1.78% | -40,4 -40,0 -0.98% | -63,8 -62,8 -1.63% | -99,0 | -143 | -147 |
|
EPS USD | Released Forecast Spread | -2,21 -2,12 -4.12% | -2,64 -2,01 -31.51% | -2,69 -2,78 3.18% | -2,58 | -3,21 | -3,11 |
| Announcement Date | 23/03/22 | 23/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,40 | 1,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -12,5 -13,7 8.73% | -15,0 -14,6 -2.86% | -18,9 -17,1 -10.32% | -19,7 -20,0 1.49% | -21,0 | -27,5 | -32,5 | -32,5 | -31,0 | -31,5 | -34,0 | -40,0 | -45,0 | |||
|
EBIT Million USD | Released Forecast Spread | -10,6 -9,93 -7.2% | -11,6 -11,1 -4.8% | -12,5 -13,2 5.13% | -15,1 -13,7 -9.52% | -18,9 -16,1 -17.14% | -19,7 -19,9 1.1% | -22,5 -20,9 -7.51% | -24,3 -23,4 -3.75% | -25,8 | -27,6 | -31,5 | -35,2 | -36,7 | -38,5 | -40,0 | -45,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,9 -10,1 -8.22% | -11,6 -11,2 -3.52% | -11,9 -13,5 11.5% | -14,6 -14,2 -2.65% | -18,4 -16,4 -12.39% | -18,8 -19,1 1.09% | -21,6 -20,6 -5.09% | -23,7 -22,9 -3.75% | -25,9 | -27,0 | -27,6 | -28,5 | -29,9 | -31,7 | -41,9 | -46,9 |
|
Net income Million USD | Released Forecast Spread | -10,9 -10,2 -6.67% | -11,6 -11,2 -3.52% | -11,9 -13,5 11.5% | -14,6 -14,2 -2.65% | -18,4 -16,4 -12.39% | -18,8 -19,0 0.93% | -21,6 -20,1 -7.61% | -23,7 -23,1 -2.65% | -26,0 | -28,5 | -31,7 | -35,4 | -36,9 | -38,7 | -33,5 | -37,5 |
|
EPS USD | Released Forecast Spread | -0,75 -0,58 -28.76% | -0,69 -0,44 -57.71% | -0,55 -0,52 -6.28% | -0,66 -0,60 -10.46% | -0,83 -0,68 -21.61% | -0,65 -0,73 10.75% | -0,64 -0,70 8.31% | -0,62 -0,68 8.63% | -0,65 | -0,71 | -0,73 | -0,78 | -0,81 | -0,86 | -0,79 | -0,89 |
| Announcement Date | 10/11/22 | 23/03/23 | 15/05/23 | 10/08/23 | 13/11/23 | 27/03/24 | 15/05/24 | 14/08/24 | - | - | - | - | - | - | - | - |
More events
Past sector events for Celcuity Inc.
| 05/09/2024 01:50 pm | PHARMAESSENTIA CORPORATION: August 2024 Sales and Revenue Release |
| 04/09/2024 01:31 am | ASCENDIS PHARMA A/S: Q2 2024 Earnings Release |
| 03/09/2024 04:35 pm | GH RESEARCH PLC: Q2 2024 Earnings Release |
| 28/08/2024 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q2 2024 Earnings Release (Projected) |
| 28/08/2024 | AKESO, INC.: Q2 2024 Earnings Release |
| 27/08/2024 06:40 pm | KEYMED BIOSCIENCES INC.: Q2 2024 Earnings Release |
| 27/08/2024 | BEIGENE, LTD.: Q2 2024 Earnings Release |
| 26/08/2024 | HITGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/08/2024 06:20 am | CLARITY PHARMACEUTICALS LTD: Q4 2024 Earnings Release |
| 23/08/2024 | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CELC Stock
- Calendar Celcuity Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition